CT引导下经皮乙醇交感神经溶解术治疗多汗症:操作步骤详解
本文介绍了CT引导下经皮乙醇交感神经溶解术的逐步操作技术,靶向胸椎T2、T3、T4椎旁交感神经节,用于治疗保守治疗无效的重度多汗症(3级或4级)。超过90%的患者术后即刻完全缓解,但多达40%在6个月内复发,长期无多汗概率为60%。手术风险包括代偿性多汗15%、霍纳综合征8%、气胸5%、严重肋间神经痛3%。
要点
- 靶点为胸椎T2、T3、T4椎旁交感神经节,位于椎体前外侧表面。
- 术后即刻完全缓解率超过90%,但6个月内复发率高达40%,长期无多汗概率为60%。
- 主要风险:代偿性多汗15%、霍纳综合征8%、气胸5%、严重肋间神经痛3%。
核心结论
- CT引导下经皮乙醇交感神经溶解术可即刻缓解重度多汗症,但6个月内复发率较高,长期无多汗概率为60%,需权衡手术风险与获益。
研究设计与样本
- 本文为操作技术综述,逐步介绍CT引导下经皮乙醇交感神经溶解术,并讨论患者选择、潜在并发症和治疗结局。
诊断标准与关键数值
- 治疗对象为保守治疗无效的重度多汗症(3级或4级)。
- 靶点为胸椎T2、T3、T4水平的椎旁交感神经节,位于椎体前外侧表面。
- 术后即刻完全缓解率超过90%,6个月内复发率高达40%,长期(超过6个月)无多汗概率为60%。
临床应用与阅片要点
- 操作目标为永久性阻断交感神经信号,靶向T2、T3、T4椎旁交感神经节。
- 需注意避免非靶点乙醇沉积导致严重肋间神经痛(风险3%)。
- 霍纳综合征风险为8%,多为自限性。
- 气胸风险为5%,代偿性多汗风险为15%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Hyperhidrosis, excessive sweating from the eccrine sweat glands, is caused by overactivity of the sympathetic nerves. Facial, axillary, and/or palmar hyperhidrosis (excessive sweating of the face, armpits, and hands) has a reported prevalence of 1%-1.6%. This condition is initially treated conservatively using a combination of topical and pharmacologic treatments. Surgical sympathectomy or percutaneous sympatholysis are treatment options for severe hyperhidrosis (grade 3 or 4) that does not respond to conservative management. The aim of intervention is to permanently disrupt the sympathetic signal by targeting the thoracic vertebral levels T2, T3, and T4 of the paravertebral ganglia, located on the anterolateral surface of the vertebral body. This review presents the step-by-step technique for CT-guided percutaneous ethanol sympatholysis and discusses patient selection for the procedure, potential complications, and treatment outcomes. Although more than 90% of patients report complete resolution of hyperhidrosis immediately after sympatholysis, as many as 40% report symptom recurrence within 6 months. The probability of remaining hyperhidrosis-free long term (ie, more than 6 months) after CT-guided sympatholysis is 60%. Procedural risks include a 15% risk of compensatory hyperhidrosis elsewhere in the body, 8% risk of Horner syndrome (mostly self-limiting), 5% risk of pneumothorax, and 3% risk of severe intercostal neuralgia due to nontarget ethanol deposition. Despite the risks, this intervention can be life-altering for those with severe disease.
引用
- Georgiades C. CT-guided Percutaneous Ethanol Sympatholysis for Hyperhidrosis: How I Do It. Radiology. 2025. PMID: 40100019. doi:10.1148/radiol.241430
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。